[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Target PharmaSolutions, Inc.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":71},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,35,54],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":4,"eligibilityCriteria":13,"healthyVolunteers":10,"sex":14,"minAge":15,"maxAge":4,"enrollmentInfo":16,"targetDuration":4,"studyType":19,"phases":4,"briefSummary":20,"conditions":21,"keywords":4,"overallStatus":23,"whyStopped":4,"lastUpdateSubmitDate":24,"lastUpdatePostDateStruct":25,"startDateStruct":28,"completionDateStruct":30,"leadSponsor":32,"locationsCount":4},"100504019",false,"NCT05842824","An Observational Study of Patients With Autoimmune Disease","Disease Cohort\n\nInclusion Criteria:\n\n\\- Adult patients at the time of enrollment with a diagnosis autoimmune disease by select ICD-10 codes in the EHR interface\n\nExclusion Criteria:\n\n* Death\n* Manual removal (sponsor or site request)\n* No EHR interface encounter \\> 3 years\n\nEngaged Cohort\n\nInclusion Criteria:\n\n* Adult patients diagnosed and managed for these conditions invited to participate\n* Ability to provide written informed consent\n\nExclusion Criteria:\n\n* Patient expressed desire to withdraw consent to complete PROs\n* Failure to complete PROs within 24 weeks of initial invitation\n* Greater than 24 months lapse of survey completion after baseline surveys completed\n* Additionally, the criteria detailed for Disease Cohort apply to the Engaged Cohort","ALL","18 Years",{"count":17,"type":18},500000,"ESTIMATED","OBSERVATIONAL","TARGET-AUTOIMMUNE is an observational research study to conduct a comprehensive review of outcomes for patients with autoimmune and related diseases. .",[22],"Autoimmune Diseases","NOT_YET_RECRUITING","2024-11-18",{"date":26,"type":27},"2024-11-20","ACTUAL",{"date":29,"type":18},"2025-03-31",{"date":31,"type":18},"2038-12-31",{"name":33,"class":34},"Target PharmaSolutions, Inc.","INDUSTRY",{"id":36,"slug":4,"hasResults":10,"nctId":37,"briefTitle":38,"officialTitle":38,"acronym":4,"eligibilityCriteria":39,"healthyVolunteers":10,"sex":14,"minAge":15,"maxAge":4,"enrollmentInfo":40,"targetDuration":4,"studyType":19,"phases":4,"briefSummary":42,"conditions":43,"keywords":4,"overallStatus":23,"whyStopped":4,"lastUpdateSubmitDate":24,"lastUpdatePostDateStruct":50,"startDateStruct":51,"completionDateStruct":52,"leadSponsor":53,"locationsCount":4},"100500421","NCT05796037","An Observational Study of Patients Living With Chronic Neurological Diseases","Disease Cohort\n\nInclusion Criteria:\n\n•Adult patients at the time of enrollment with a diagnosis of ADRD, MCI, PD, or MS by select ICD-10 codes in the EHR interface\n\nExclusion Criteria:\n\n* Death\n* Manual removal (sponsor or site request)\n* No EHR interface encounter \\> 3 years\n\nEngaged Cohort\n\nInclusion Criteria:\n\n* Adult patients diagnosed and managed for these conditions invited to participate\n* Ability to provide written informed consent (or have a legally authorized representative to provide informed consent)\n* Care partners may be invited to participate in surveys and will provide informed consent.\n\nExclusion Criteria:\n\n* Patient expressed desire to withdraw consent to complete PROs\n* Care partner expressed desire to withdraw consent to complete PROs\n* Failure to complete PROs within 24 weeks of initial invitation\n* Greater than 24 months lapse of survey completion after baseline surveys completed\n* Additionally, the criteria detailed for Disease Cohort apply to the Engaged Cohort\n\nAge Cohort\n\nInclusion Criteria:\n\n•Adult patients aged 60 and older at time of enrollment\n\nExclusion Criteria:\n\n* Death\n* Manual removal (sponsor or site request)\n* No EHR interface encounter \\> 3 years",{"count":41,"type":18},1500000,"TARGET-NEURO is an observational research study to conduct a comprehensive review of outcomes for patients living with chronic neurological diseases: Alzheimer's disease and related dementia (ADRD), mild cognitive impairment (MCI), Parkinson's disease (PD), and multiple sclerosis (MS).",[44,45,46,47,48,49],"Neurological Diseases or Conditions","Dementia of Alzheimer Type","Alzheimer Disease","Mild Cognitive Impairment","Parkinson Disease","Multiple Sclerosis",{"date":26,"type":27},{"date":29,"type":18},{"date":31,"type":18},{"name":33,"class":34},{"id":55,"slug":4,"hasResults":10,"nctId":56,"briefTitle":57,"officialTitle":57,"acronym":4,"eligibilityCriteria":58,"healthyVolunteers":10,"sex":14,"minAge":15,"maxAge":4,"enrollmentInfo":59,"targetDuration":4,"studyType":19,"phases":4,"briefSummary":61,"conditions":62,"keywords":4,"overallStatus":23,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":70,"locationsCount":4},"100504018","NCT05842811","An Observational Study of Patients With Metabolic Syndrome and Related Conditions","Disease Cohort\n\nInclusion Criteria:\n\n\\- Adult patients at the time of enrollment with a diagnosis of metabolic syndrome or related conditions by ICD-10 code or with clinically calculated BMI ≥ 30 in the EHR\u002Fhealth system interface\n\nExclusion Criteria:\n\n* Death\n* Manual removal (sponsor or site request)\n* No EHR interface encounter \\> 3 years\n\nEngaged Cohort\n\nInclusion Criteria:\n\n* Adult patients diagnosed and managed for these conditions invited to participate\n* Ability to provide written informed consent\n\nExclusion Criteria:\n\n* Patient expressed desire to withdraw consent to complete PROs\n* Failure to complete PROs within 24 weeks of initial invitation\n* Greater than 24 months lapse of survey completion after baseline surveys completed\n* Additionally, the criteria detailed for Disease Cohort apply to the Engaged Cohort",{"count":60,"type":18},2000000,"TARGET-METABOLIC is an observational research study to conduct a comprehensive review of outcomes for patients with metabolic syndrome and related conditions.",[63],"Metabolic Syndrome","2023-04-24",{"date":66,"type":27},"2023-05-06",{"date":68,"type":18},"2023-05-24",{"date":31,"type":18},{"name":33,"class":34},""]